BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the completion of the acquisition of Biotheus ...

Investing.com's Fair Value model demonstrated its effectiveness once again, identifying a significant opportunity in BioNTech SE (NASDAQ:BNTX) that resulted in a remarkable 51% return over just six ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

mRNA therapies have been in the spotlight since BioNTech and Pfizer used the technology to create a vaccine against COVID-19 last year. But it was cancer that the German biotech originally ...

Clinical trial using the same technology as Covid-19 vaccines is designed to fight colorectal cancer and prevent it from ...

Mike Aughenbaugh, Associate Target Market Manager, Swagelok, joins us to discuss his article that featured in the July/August 2024 issue of Oilfield Technology magazine. This strategic bolt-on ...